Nesfatin-1 ameliorates blood-brain barrier dysfunction in Alzheimer’s disease by targeting VEGF-R1 and reducing cellular senescence in brain vascular endothelial cells. This evidence concerns the gene FLT1 and early-onset autosomal dominant Alzheimer disease.